Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Atherosclerosis Reports|August 7, 2002
Erectile dysfunction and atherosclerosisRobert A Kloner, Mark Speakman
Nature Clinical Practice. Urology|August 4, 2007
Acute urinary retention: medical management and the identification of risk factors for preventionJay Khastgir, Azhar Khan, Mark Speakman
International Urology and Nephrology|June 17, 2004
Carcinosarcoma of the ureter: a rare, pleomorphic, aggressive malignancyPetros Perimenis, Anastasios Athanasopoulos, John Geragthy, et al.
BJU International|March 25, 2014
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UKMark Speakman, Roger Kirby, Scott Doyle, et al.
British Journal of Hospital Medicine (London, England : 2005)|April 28, 2020
Non-visible haematuria: would discontinuing urgent investigation have a visible impact?Joseph B John, Alberto Coscione, Peter Acher, et al.
Current Medical Research and Opinion|June 21, 2008
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndromeMark Speakman, Vik Khullar, Anthony Mundy, et al.
Urologic Nursing|January 22, 2005
Pelvic floor exercises for treating post-micturition dribble in men with erectile dysfunction: a randomized controlled trialGrace Dorey, Mark Speakman, Roger Feneley, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 6, 2004
Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunctionGrace Dorey, Mark Speakman, Roger Feneley, et al.
The Journal of Sexual Medicine|February 27, 2008
British Society for Sexual Medicine guidelines on the management of erectile dysfunctionGeoff Hackett, Phil Kell, David Ralph, et al.
European Urology|August 13, 2013
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trialPhilip van Kerrebroeck, Christopher Chapple, Ted Drogendijk, et al.
Pageof 2